|
Mr. Gregg joined Vasogen’s Board of Directors in 1999 was appointed Vice Chairman in November 2005 and became Chairman of the Board in March 2006.
Mr. Gregg currently serves as President and Chief Executive Officer of DexCom Inc. In 1996 Mr. Gregg was appointed President and Chief Operating Officer of MiniMed Inc. now a world leader in insulin pump therapy and continuous glucose monitoring and he was instrumental in Medtronic’s US$3.4 billion acquisition of the company in 2001. He retired as President of Medtronic MiniMed in 2002. He also served in executive positions with Smith & Nephew plc a diversified healthcare product company and Allergan Inc. a leading ophthalmic device and pharmaceutical company. He is currently a Special Venture Partner with Galen Associates a private equity firm specializing in the healthcare sector serves on the boards of DexCom Inc. and LMS Medical Systems Inc. and is Executive Chairman of Patton Medical Devices LC. Mr. Gregg also served on the Boards of Amylin Pharmaceuticals Inc. and Ocular Sciences Inc. which was purchased by The Cooper Companies Inc. for US$1.2 billion last year. | 